BR112019014942A2 - terapia de combinação para tratamento de doenças da pele - Google Patents
terapia de combinação para tratamento de doenças da pele Download PDFInfo
- Publication number
- BR112019014942A2 BR112019014942A2 BR112019014942-2A BR112019014942A BR112019014942A2 BR 112019014942 A2 BR112019014942 A2 BR 112019014942A2 BR 112019014942 A BR112019014942 A BR 112019014942A BR 112019014942 A2 BR112019014942 A2 BR 112019014942A2
- Authority
- BR
- Brazil
- Prior art keywords
- substituted
- unsubstituted
- composition
- indolylmethane
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762448808P | 2017-01-20 | 2017-01-20 | |
| US62/448,808 | 2017-01-20 | ||
| PCT/IB2018/000109 WO2018134683A1 (en) | 2017-01-20 | 2018-01-19 | Combination therapy for treatment of skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019014942A2 true BR112019014942A2 (pt) | 2020-04-14 |
Family
ID=61731720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019014942-2A BR112019014942A2 (pt) | 2017-01-20 | 2018-01-19 | terapia de combinação para tratamento de doenças da pele |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11241467B2 (https=) |
| EP (1) | EP3570889A1 (https=) |
| JP (2) | JP7123058B2 (https=) |
| CN (2) | CN116036290A (https=) |
| AU (1) | AU2018209393B2 (https=) |
| BR (1) | BR112019014942A2 (https=) |
| CA (1) | CA3050208A1 (https=) |
| WO (1) | WO2018134683A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7169591B2 (ja) * | 2016-09-15 | 2022-11-11 | スキンテック ライフ サイエンス リミテッド | 皮膚疾患の処置のためのｄｉｍの舌下又は頬側の投与 |
| US11241467B2 (en) | 2017-01-20 | 2022-02-08 | Skintech Life Science Limited | Composition for treating acne |
| WO2025097063A1 (en) * | 2023-11-01 | 2025-05-08 | Skintech Life Science Limited | Topical dim compositions and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5665367A (en) * | 1996-09-27 | 1997-09-09 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin care compositions containing naringenin and/or quercetin and a retinoid |
| US6599913B1 (en) * | 2001-06-29 | 2003-07-29 | Schering Corporation | Treating allergic and inflammatory conditions |
| US6767563B2 (en) * | 2001-10-30 | 2004-07-27 | Michael D. Farley | Immune functions |
| US20030166583A1 (en) * | 2002-02-22 | 2003-09-04 | Oliver Yoa-Pu Hu | Dermal cytochrome P450 1A inhibitors and enhancers |
| BRPI0717753B1 (pt) * | 2006-10-27 | 2022-04-12 | Bioresponse, Llc | Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição |
| FR2908604B1 (fr) * | 2006-11-16 | 2013-06-28 | Physcience | Complement alimentaire pour la prevention ou la lutte contre la chute des cheveux, l'acne, l'hirsutisme et la secretion sudorale apocrine excessive. |
| RU2419426C1 (ru) * | 2010-04-26 | 2011-05-27 | Всеволод Иванович Киселев | Лекарственное средство на основе дииндолилметана (dim) с повышенной биодоступностью и его использование в лечении гиперпластических и воспалительных заболеваний человека |
| GB201105050D0 (en) * | 2011-03-25 | 2011-05-11 | Iiaa Ltd | Pharmaceutical agent |
| EP2696868A1 (en) * | 2011-04-12 | 2014-02-19 | Nestec S.A. | Nutritional compositions including branched chain fatty acids and methods of using same |
| WO2014168925A1 (en) * | 2013-04-08 | 2014-10-16 | Virginia Commonwealth University | Compositions to alleviate presystemic metabolism of opioids |
| DE102013104441A1 (de) * | 2013-04-30 | 2014-10-16 | Bodo C. Melnik | Akne-Medikament und Verfahren zu seiner Herstellung |
| GB2528482A (en) * | 2014-07-23 | 2016-01-27 | Skintech Life Science Ltd | Pharmaceutical agent |
| JP7169591B2 (ja) * | 2016-09-15 | 2022-11-11 | スキンテック ライフ サイエンス リミテッド | 皮膚疾患の処置のためのｄｉｍの舌下又は頬側の投与 |
| US11241467B2 (en) | 2017-01-20 | 2022-02-08 | Skintech Life Science Limited | Composition for treating acne |
-
2018
- 2018-01-19 US US16/479,158 patent/US11241467B2/en active Active
- 2018-01-19 BR BR112019014942-2A patent/BR112019014942A2/pt not_active Application Discontinuation
- 2018-01-19 AU AU2018209393A patent/AU2018209393B2/en not_active Ceased
- 2018-01-19 EP EP18712449.0A patent/EP3570889A1/en not_active Withdrawn
- 2018-01-19 CN CN202310057791.0A patent/CN116036290A/zh active Pending
- 2018-01-19 WO PCT/IB2018/000109 patent/WO2018134683A1/en not_active Ceased
- 2018-01-19 JP JP2019537351A patent/JP7123058B2/ja active Active
- 2018-01-19 CN CN201880019777.9A patent/CN110446505A/zh active Pending
- 2018-01-19 CA CA3050208A patent/CA3050208A1/en active Pending
-
2021
- 2021-12-29 US US17/565,439 patent/US20220193167A1/en not_active Abandoned
-
2022
- 2022-08-09 JP JP2022127265A patent/JP7481402B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018209393A1 (en) | 2019-08-08 |
| JP7123058B2 (ja) | 2022-08-22 |
| CN110446505A (zh) | 2019-11-12 |
| US20200138884A1 (en) | 2020-05-07 |
| AU2018209393B2 (en) | 2024-02-15 |
| EP3570889A1 (en) | 2019-11-27 |
| WO2018134683A1 (en) | 2018-07-26 |
| RU2019124938A (ru) | 2021-02-20 |
| RU2019124938A3 (https=) | 2021-05-27 |
| US11241467B2 (en) | 2022-02-08 |
| US20220193167A1 (en) | 2022-06-23 |
| JP2022169626A (ja) | 2022-11-09 |
| JP7481402B2 (ja) | 2024-05-10 |
| JP2020506169A (ja) | 2020-02-27 |
| CN116036290A (zh) | 2023-05-02 |
| CA3050208A1 (en) | 2018-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7481402B2 (ja) | 皮膚疾患の処置のための併用療法 | |
| TW201615221A (zh) | 炎症用藥臨床新應用 | |
| US9370501B2 (en) | Treatment of pain with topical diclofenac | |
| US20240390326A1 (en) | Sublingual or buccal administration of dim for treatment of skin diseases | |
| RU2701720C1 (ru) | Комбинации пальмитоилэтаноламида для лечения хронической боли | |
| CN114786660A (zh) | 使用mtorc1调节剂的治疗方法 | |
| US8546450B1 (en) | Treatment of pain with topical diclofenac compounds | |
| BR112021001328A2 (pt) | composições de licopeno e métodos para proteger a pele contra a radiação ultravioleta | |
| RU2775974C2 (ru) | Комбинированная терапия для лечения кожных заболеваний | |
| JP5484704B2 (ja) | 高齢者の発熱症状抑制剤 | |
| HK40011827A (en) | Combination therapy for treatment of skin diseases | |
| Burchakov et al. | The antioxidant, anti-inflammatory, and sedative effects of melatonin: results of clinical trials | |
| CA3087789A1 (en) | Oral formulations of metronidazole and methods of treating an infection using same | |
| TWI735658B (zh) | 用於減少代謝症候群之組合物及其應用 | |
| Monira | Evaluation of Photo-Degradation of alatrol®(Cetirizine hydrochloride) under different Extreme lighting condition: An UV Analysis | |
| HK40008900A (en) | Sublingual or buccal administration of dim for treatment of skin diseases | |
| Nguyen et al. | Journal of Health Science and Development | |
| Rajamannan | Próximo pago de haberes | |
| Hau | Voluntary ingestion of buprenorphine in mice | |
| TW202137997A (zh) | 用於減少代謝症候群之組合物及其應用 | |
| CN107970248A (zh) | 异甘草酸在制备治疗高血压药物中的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B25G | Requested change of headquarter approved |
Owner name: SKINTECH LIFE SCIENCE LIMITED (GB) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |